Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4nb6 | 444 | Nuclear receptor ROR-gamma |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 1.000 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.542 | |
| 4nie | NBH | Nuclear receptor ROR-gamma | / | 0.501 | |
| 3kyt | HC2 | Nuclear receptor ROR-gamma | / | 0.494 | |
| 1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.447 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.444 | |
| 1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 2nnh | REA | Cytochrome P450 2C8 | / | 0.443 | |
| 3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.441 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.440 |